Aorta Disease, Peripheral Artery Disease
Conditions
Keywords
Revascularization of Aorta or Peripheral artery
Brief summary
The purpose of this study is to evaluate the clinical results of patients who received revascularization of the aorta and peripheral artery at Asan Medical Center.
Detailed description
This study is a single center retrospective and prospective observational study to evaluate the clinical results of patients who received revascularization of the aorta and peripheral artery at asan medical center. Data will be collected on approximately 6,000 subjects in asan medical center. Individuals will be followed up at 1, 6, and 12 months, 3, 5years up to 10 years by telephone call or hospital visit. Data collected during all follow-up visits will include a composite of major adverse limb events, or death from any cause.
Interventions
OTHERTreatment
EVAR,TEVAR,PTA
Sponsors
Asan Medical Center
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients underwent Revascularization of Aorta or Peripheral artery from 2011 at the Peripheral Vascular Disease Center, Asan Medical Center * Patients with aortic and peripheral artery disease are defined as: Thoacic aorta disease/ abdominal aorta disease 1. Aneurysm 2. Aortic dissection 3. Penetrating aortic ulcer Peripheral artery occlusive disease 1. Chronic Limb-Threatening Ischemia 2. Claudication 3. Acute limb ischemia
Exclusion criteria
* For prospective cohort, not agreeing to participate with written informed consent form
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of death from any cause | 10years | all-cause death |
| Rate of major Adverse Limb Events | 10years | above-ankle amputation of the index limb,major index-limb reintervention including new bypass,interposition graft revision,thrombectomy, or thrombolysis |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of myocardial Infarction | 10years | Spontaneous MI |
| Rate of vascular complication | 10years | Vascular complication |
| Rate of bleeding | 10years | TIMI bleeding |
| Rate of death from all cause including cardiovascular death | 10years | cardiovascular death,Non-cardiovascular death |
| Rate of limb amputation | 10years | Additional limb amputation of the index limb,Additional limb amputation of the non-index limb |
| Rate of reintervention of aorta , reintervention of index limb or non-index limb | 10years | Reintervention of aorta , reintervention of index limb or non-index limb |
| Success of the procedure | 10years | PTA (target artery path) TEVAR and EVAR if aneurysm is diagnosed (the endograft is deployed accurately and the aneurysm is excluded from the circulation), if dissection is diagnosed(closure of the primary entry tear (i.e. absence of type Ia endoleak) and induction of false lumen thrombosis) |
| Rate of stroke | 10years | Ischemic , hemorrhagic , mixed Stroke |
Countries
South Korea
Contacts
Primary ContactJung hwa Lee, RN
Backup ContactSeung-Whan Lee
Outcome results
None listed